Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$74.20
pos +0.78
+1.10%
Today's Range: 73.28 - 74.19 | GILD Avg Daily Volume: 8,637,000
Last Update: 07/21/17 - 12:39 PM EDT
Volume: 3,524,537
YTD Performance: 2.53%
Open: $73.32
Previous Close: $73.42
52 Week Range: $77.92 - $120.37
Oustanding Shares: 1,306,728,398
Market Cap: 95,025,289,103
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 9 10
Moderate Buy 1 1 1 1
Hold 9 8 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.12 2.00 2.00 1.95
Latest Dividend: 0.52
Latest Dividend Yield: 2.86%
Dividend Ex-Date: 06/14/17
Price Earnings Ratio: 7.69
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
7.69 7.70 30.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.41% -15.28% -17.68%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.90 1.70 0.39
Net Income -25.50 3.40 0.63
EPS -16.50 4.00 0.70
Earnings for GILD:
EBITDA 18.79B
Revenue 30.39B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $2.11 $2.00 $7.98 $7.18
Number of Analysts 5 5 7 3
High Estimate $2.29 $2.15 $8.72 $7.59
Low Estimate $1.87 $1.88 $6.86 $6.46
Prior Year $3.03 $2.70 $11.37 $7.98
Growth Rate (Year over Year) -30.23% -25.78% -29.78% -10.07%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The two giants likely won't be home runs, but they remain stalwarts in the biotech space.
The two giants likely won't be home runs, but they remain stalwarts in the biotech space.
Bullish and bearish reversals for this week.
There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

The Market Advance Narrows Real Money Pro($)

"For a day where the S&P was essentially flat, there was a lot going on beneath the surface.
Banks, tech and healthcare are all seeing renewed buying.

Takeaways and Observations Real Money Pro($)

  Top 10 Reasons the Lambs May Be Sheared ... or Slaughtered.    Stated simply, I see a trend change. &nbs…
"How does it feel, how does it feel? To be without a home Like a complete unknown, like a rolling stone." -- Bob Dylan, Like A Roll…
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, "

Some 'Value Traps' I See Real Money Pro($)

"A value trap is a stock that appears to be cheap because the stock has been trading at low multiples of earnings, cash flow or …

Columnist Conversations

Its been a rough year for GIS.  Heavy overhead pressure from the stock's 200 day moving average, which th...
Twitter (TWTR)  is back up to the 62% retracement level of its 2016 high and 2017 low. Above it is&n...
Sears (SHLD) announced they plan to start selling Kenmore appliances on Amazon (AMZN). SHLD shares are surging...
Today is going to be a great webinar after the close, with the BEST retail analyst on the planet.  Stacey...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.